AstraZeneca says EU legal action over COVID-19 vaccine supply is without merit
- Country:
- United Kingdom
AstraZeneca on Monday said that legal action by the European Union against the pharmaceutical company over the supply of its COVID-19 vaccine was without merit and pledged to defend itself strongly in court.
"AstraZeneca has fully complied with the Advance Purchase Agreement with the European Commission and will strongly defend itself in court. We believe any litigation is without merit and we welcome this opportunity to resolve this dispute as soon as possible," AstraZeneca said in a statement.
ALSO READ
-
€40m Boost Opens New Doors for Cultural and Creative Businesses in Belgium
-
Belize Communities Take the Lead in New Push for Jobs, Skills and Stronger Futures
-
Hotter Years, More Cavities? Understanding Link Between Climate and Dental Health
-
Europe’s Rare Earth Wake-Up Call: Turning Years of Research Into Factories That Last
-
Lebanon’s Small Business Owners Build Skills and Market Links With EU and ILO Support
Google News